Bright Minds Biosciences Inc.

DRUG | NASDAQ

Price Alert Chart Builder DCF Calculator

$61.44

+$1.98 (+3.33%)

Sep 22, 2026, 12:23 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Sep 29, 2025	FY 2024 Sep 29, 2024	FY 2023 Sep 29, 2023	FY 2022 Sep 29, 2022	FY 2021 Sep 29, 2021	FY 2020 Sep 29, 2020
Net Income	-12.23M	-2.8M	-7.37M	-14.96M	-8.65M	-480.38K
Depreciation & Amortization	76.87K	73.36K	72.45K	6.04K	n/a	n/a
Stock-Based Compensation	3.18M	839.77K	1.15M	875.06K	880.62K	161.3K
Other Working Capital	917.84K	53.06K	-1.06M	769.77K	416.23K	30.69K
Other Non-Cash Items	-276.84K	-1.18K	65.1K	-227.4K	144.76K	161.3K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	554.99K	39.81K	-941.72K	724.13K	306.08K	30.69K
Operating Cash Flow	-8.69M	-1.85M	-7.02M	-13.59M	-7.32M	-288.39K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-100.15K	-89.73K	-86.11K	-7.16K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-360.14K	n/a	1.06M	1.17M	-1.69M	n/a
Financial Cash Flow	85.57M	810.57K	2.19M	5.2M	26.06M	1.01M
Net Cash Flow	77.19M	-1.03M	-4.88M	-8.13M	18.96M	719.94K
Free Cash Flow	-8.69M	-1.85M	-7.02M	-13.59M	-7.32M	-288.39K
Adj. Free Cash Flow	-11.87M	-2.69M	-8.18M	-14.46M	-8.2M	-449.69K
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-8.69M	-1.85M	-7.02M	-13.59M	-7.32M	-288.39K